Shin Nippon Biomedical Laboratories, Ltd.
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
8
Ending by 2030
Oct 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 21, 2026The maintenance fee for Test substance administration system for animal experiment (US 10,293,123) comes due Nov 21, 2026. Unpaid by May 21, 2027, it lapses early.
- 1 fee due Feb 11, 2027The maintenance fee for Intranasal pharmaceutical compositions with improved pharmacokinetics (US 9,101,539) comes due Feb 11, 2027. Unpaid by Aug 11, 2027, it lapses early.
- 1 fee due Mar 5, 2027The maintenance fee for Intranasal Delivery Devices (US 11,744,967) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
- 1 fee due May 5, 2027The maintenance fee for Methods and compositions for intranasal delivery (US 10,463,723) comes due May 5, 2027. Unpaid by Nov 5, 2027, it lapses early.
- 1 fee due Jul 16, 2027The maintenance fee for Pharmaceutical Compositions (US 11,872,314) comes due Jul 16, 2027. Unpaid by Jan 18, 2028, it lapses early.
- 1 fee due Oct 26, 2027The maintenance fee for Primate Restraint Device (US 9,320,582) comes due Oct 26, 2027. Unpaid by Apr 26, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,673,360 | Compositions that enable rapid-acting and highly absorptive intranasal administration In force · USPTO record | In force | USPTO record | |
| US 10,195,139 | Preparation for transnasal application In force · USPTO record | In force | USPTO record | |
| US 10,293,123 | Test substance administration system for animal experiment In force · USPTO record | In force | USPTO record | |
| US 8,337,817 | Preparation for transnasal application In force · USPTO record | In force | USPTO record | |
| US 9,101,539 | Intranasal pharmaceutical compositions with improved pharmacokinetics In force · USPTO record | In force | USPTO record | |
| US 9,320,582 | Primate Restraint Device In force · High confidence | In force | High confidence | |
| US 8,899,184 | Primate Restraint Device In force · High confidence | In force | High confidence | |
| US 8,827,946 | Intranasal granisetron and nasal applicator In force · USPTO record | In force | USPTO record | |
| US 10,463,723 | Methods and compositions for intranasal delivery In force · USPTO record | In force | USPTO record | |
| US 9,363,979 | Primate Restraint Device In force · High confidence | In force | High confidence |
Also on record, not counted in the 23: 5 patents in force now held by others · 9 lapsed for an unpaid fee · 4 ended at full term · 1 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 9 no status recorded